Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 42, Issue 8 (Aug 2004)

Issues

High in-hospital mortality of intensive care patients with nucleated red blood cells in blood

Axel Stachon
  • Institute of Clinical Chemistry, Transfusion and Laboratory Medicine, BG-University Hospital Bergmannsheil, Ruhr-University Bochum, Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Tim Holland-Letz / Michael Krieg
  • Institute of Clinical Chemistry, Transfusion and Laboratory Medicine, BG-University Hospital Bergmannsheil, Ruhr-University Bochum, Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2004.151

Abstract

The detection of nucleated red blood cells (NRBCs) in blood of patients suffering from a variety of severe diseases is known to be highly associated with increased mortality. Blood analyzers to routinely measure NRBC concentrations are now available. However, the diagnostic and prognostic significance of this parameter for intensive care patients has not been evaluated. Using a Sysmex XE-2100 analyzer, NRBC concentrations were determined in blood samples from 421 patients treated in intensive care units (general and accident surgery, cardiothoracic surgery, and internal medicine) of a university hospital. NRBCs were found at least once in 19.2% of all patients. The mortality of NRBC-positive patients (n = 81) was 42.0% (n = 34); this was significantly higher (p < 0.001) than the mortality of NRBC-negative patients (5.9%, n = 340). The NRBC concentration was 115 ± 4 × 106/l (median 40 × 106/l; range 20–2930 × 106/l) at initial detection of NRBCs in the blood. Mortality increased with increasing NRBC concentration and increasing frequency of occurrence. With regard to in-hospital mortality, NRBCs in blood showed sensitivity and specificity of 63.0% and 87.2%, respectively. The detection of NRBCs is highly predictive of death, the odds ratio after adjustment for other laboratory prognostic indicators being 1.01 (p < 0.01) for each increase in the NRBC concentration of +1 × 106/l. NRBCs were detected for the first time, on average, 13 days (median 8 days) before death. The routine analysis of NRBCs in blood is of high prognostic power with regard to in-hospital mortality of critically ill patients. Therefore, this parameter may serve as an early indicator for patients at increased mortality risk.

Keywords: intensive care; mortality; nucleated red blood cells

References

  • 1

    Schwartz SO. Significance of nucleated red blood cells in peripheral blood. J Am Med Assoc 1954; 154:1339–40.Google Scholar

  • 2

    Delsol G, Guiu-Godfrin B, Guiu M, Pris J, Corberand J, Fabre J. Leukoerythroblastosis and cancer frequency, prognosis, and physiopathologic significance. Cancer 1979; 44:1009–13.Google Scholar

  • 3

    Budmiger H, Graf C, Streuli RA. The leukoerythroblastic blood picture. Incidence and clinical significance. Schweiz Rundsch Med Prax 1984; 73:1489–93.Google Scholar

  • 4

    Weick JK, Hagedorn AB, Linman JW. Leukoerythroblastosis. Mayo Clin Proc 1974; 49:110–3.Google Scholar

  • 5

    West CD, Ley AB, Pearson OH. Myelophthisic anemia in cancer of the breast. Am J Med 1955; 18:923–31.Google Scholar

  • 6

    Mettier SR. Hematologic aspects of space consuming lesions of the bone marrow (myelophtisic anemia). Ann Intern Med 1940; 14:436–48.CrossrefGoogle Scholar

  • 7

    Andres WA. Normoblastemia after thermal injury. Am J Surg 1976; 131:725–6.Google Scholar

  • 8

    Tavassoli M. Erythroblastemia. West J Med 1975; 122:194–8.Google Scholar

  • 9

    Stachon A, BöningA, Krismann M, Weisser H, Laczkovics A, Skipka G, et al. Prognostic significance of erythroblasts in blood after cardiothoracic surgery. Clin Chem Lab Med 2001; 39:239–43.Google Scholar

  • 10

    Ruzicka K, Veitl M, Thalhammer-Scherrer R, Schwarzinger I. The new hematology analyzer Sysmex XE-2100: performance evaluation of a novel white blood cell differential technology. Arch Pathol Lab Med 2001; 125:391–6.Google Scholar

  • 11

    Walters J, Garrity P. Performance evaluation of the Sysmex XE-2100 hematology analyser. Lab Hematol 2000; 6:83–92.Google Scholar

  • 12

    Briggs C, Harrison P, Grant D, Staves J, Maciag T. New quantitative parameters on recently introduced automated blood cell counter – the XE 2100™. Clin Lab Haematol 2000; 22:345–50.Google Scholar

  • 13

    Stachon A, Sondermann N, Krieg M. Incidence of nucleated red blood cells in the blood of hospitalised patients. Infusion Ther Transfus Med 2001; 28:263–6.Google Scholar

  • 14

    Stachon A, Sondermann N, Imöhl M, Krieg M. Nucleated red blood cells indicate high risk for in-hospital mortality. J Lab Clin Med 2002; 140:407–12.Google Scholar

  • 15

    Böning A, Stachon A, Weisser H, Krismann M, Skipka G, Laczkovics A, et al. Postoperative cholesterol and erythroblasts as a parameter of perioperative mortality after cardiothoracic surgery. Z Herz Thorax Gefäßchir 2001; 15:242–8.Google Scholar

  • 16

    Stachon A, Eisenblätter K, Köller M, Holland-Letz T, Krieg M. Cytokines and erythropoietin in the blood of patients with erythroblastemia. Acta Haematol 2003; 110:204–6.Google Scholar

  • 17

    Livingston DH, Anjarina D, Wu J, Hauser CJ, Chang V, Deitch EA, et al. Bone marrow failure following severe injury in humans. Ann Surg 2003; 238:748–53.Google Scholar

About the article

Corresponding author: Dr. A. Stachon, Institute of Clinical Chemistry, Transfusion and Laboratory Medicine, BG-University Hospital Bergmannsheil, Ruhr-University, Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany. Phone: +49-234-3020, Fax: +49-234-302-6614, E-mail:


Received: 2004-02-02

Accepted: 2004-04-26

Published Online: 2005-06-01

Published in Print: 2004-08-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2004.151.

Export Citation

© Walter de Gruyter. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
G. Da Rin, M. Vidali, F. Balboni, A. Benegiamo, M. Borin, M. L. Ciardelli, F. Dima, A. Di Fabio, A. Fanelli, F. Fiorini, S. Francione, L. Germagnoli, M. Gioia, T. Lari, M. Lorubbio, A. Marini, A. Papa, M. Seghezzi, L. Solarino, S. Pipitone, E. Tilocca, and S. Buoro
International Journal of Laboratory Hematology, 2017
[2]
Steven W. Purtle, Clare M. Horkan, Takuhiro Moromizato, Fiona K. Gibbons, and Kenneth B. Christopher
Critical Care, 2017, Volume 21, Number 1
[3]
Dan T.A. Eisenberg, Judith B. Borja, M. Geoffrey Hayes, and Christopher W. Kuzawa
American Journal of Human Biology, 2017, Page e22962
[4]
José Gildo de Moura Monteiro Júnior, Dilênia de Oliveira Cipriano Torres, Maria Cleide Freire Clementino da Silva, Tadzia Maria de Brito Ramos, Marilene Leite Alves, Wellington Jorge Nunes Filho, Edgar Paulo Damasceno, Antônio Fernandes Brunet, Márcio Sommer Bittencourt, Rodrigo Pinto Pedrosa, Dário Celestino Sobral Filho, and Sheila Alexander
PLOS ONE, 2015, Volume 10, Number 12, Page e0144259
[5]
C. Tantanate and C. Klinbua
International Journal of Laboratory Hematology, 2015, Volume 37, Number 3, Page 341
[6]
David B. Nelson, Nicole P. Yost, and F. Gary Cunningham
Obstetrics & Gynecology, 2014, Volume 124, Number 1, Page 40
[7]
Sapana Desai, Stephen L. Jones, Krista L. Turner, Jeff Hall, and Laura J. Moore
Surgical Infections, 2012, Volume 13, Number 6, Page 360
[8]
D. T. A. Eisenberg, M. G. Hayes, and C. W. Kuzawa
Proceedings of the National Academy of Sciences, 2012, Volume 109, Number 26, Page 10251
[9]
Rupen Shah, Subhash Reddy, H. Mathilda Horst, Jerry Stassinopoulos, Jack Jordan, and Ilan Rubinfeld
The American Journal of Surgery, 2012, Volume 203, Number 3, Page 343
[10]
Paolo Danise, Mariacaterina Maconi, Fabio Barrella, Anna Di Palma, Daniela Avino, Adele Rovetti, Maria Gioia, and Giovanni Amendola
Clinical Chemistry and Laboratory Medicine (CCLM), 2012, Volume 50, Number 2
[11]
Axel Stachon, Reiner Kempf, Tim Holland-Letz, Jochen Friese, Andreas Becker, and Michael Krieg
Clinica Chimica Acta, 2006, Volume 366, Number 1-2, Page 329
[12]
C. Thomas Nebe, Herrad Baurmann, Gudrun Kuling, and Heinz Diem
LaboratoriumsMedizin, 2008, Volume 32, Number 6, Page -
[13]
C. Thomas Nebe, Herrad Baurmann, Gudrun Kuling, and Heinz Diem
LaboratoriumsMedizin, 2008, Volume 32, Number 6, Page 406
[16]
Axel Stachon, Elmar Segbers, Steffen Hering, Reiner Kempf, Tim Holland-Letz, and Michael Krieg
Clinical Chemistry and Laboratory Medicine, 2008, Volume 46, Number 6
[17]
Sandra Kuert, Tim Holland-Letz, Jochen Friese, and Axel Stachon
Clinical Chemistry and Laboratory Medicine, 2011, Volume 49, Number 2
[18]
Axel Stachon, Tim Holland-Letz, Reiner Kempf, Andreas Becker, Jochen Friese, and Michael Krieg
Clinical Chemistry and Laboratory Medicine (CCLM), 2006, Volume 44, Number 8
[20]
Axel Stachon, Andreas Becker, Reiner Kempf, Tim Holland-Letz, Jochen Friese, and Michael Krieg
The Journal of Trauma: Injury, Infection, and Critical Care, 2008, Volume 65, Number 3, Page 666

Comments (0)

Please log in or register to comment.
Log in